\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ resection\\ was\\ curative\ \(0\)\
\-\ ct\ \(23117\)\
\-\ \\ 3\\-cm\\,\\ soft\\ tissue\\ density\\ mass\\ within\\ the\\ left\\ inferior\\ meatus\\ with\\ extension\\ into\\ the\\ left\\ nasal\\ passage\\.\ \(1\)\
\-\ \\ \ \(1082074\)\
\-\ scattered\\ areas\\ of\\ calcification\\ with\\ remodeling\\ of\\ the\\ bone\\.\ \(0\)\
\-\ no\\ definite\\ osseous\\ destruction\\.\ \(0\)\
\-\ mild\\ mucoperiosteal\\ thickening\\ of\\ the\\ bilateral\\ maxillary\\ and\\ frontal\\ sinuses\\,\\ as\\ well\\ as\\ the\\ ethmoidal\\ air\\ cells\\.\\ \ \(0\)\
\-\ mr\ \(14\)\
\-\ complex\\ mass\\ with\\ heterogeneous\\ signal\\ characteristics\\ and\\ heterogeneous\\ enhancement\\ characteristics\\ in\\ the\\ left\\ nasal\\ passage\\.\\ \ \(0\)\
\-\ interface\\ with\\ the\\ left\\ nasal\\ lacrimal\\ duct\\ and\\ superior\\ most\\ aspect\\ of\\ the\\ left\\ incisors\\.\\ \ \(0\)\
\-\ modeling\\ of\\ the\\ surrounding\\ osseous\\ structures\\ without\\ evidence\\ of\\ destruction\\ or\\ infiltration\\.\ \(0\)\
\-\ pleomorphic\\ adenoma\ \(4\)\
\-\ nasal\\ vault\\ masses\\ \\(non\\-aggressive\\)\ \(0\)\
\-\ sinonasal\\ polyp\ \(0\)\
\-\ inverted\\ papilloma\ \(0\)\
\-\ pleomorphic\\ adenoma\ \(4\)\
\-\ hemangioma\\ \\(epistaxis\\)\ \(0\)\
\-\ pyogenic\\ granuloma\\ \\(pedunculated\\ lobular\\ mass\\)\ \(0\)\
\-\ granuloma\\ gravidarum\\ \\(hemangioma\\ of\\ pregnancy\\)\\ in\\ women\ \(0\)\
\-\ hemangiopericytoma\ \(13\)\
\-\ juvenile\\ nasopharyngeal\\ angiofibroma\ \(0\)\
\-\ ectopic\\ salivary\\ gland\ \(0\)\
\-\ 44\\ y\\.o\\.\\ man\\ presents\\ with\\ blockage\\ of\\ the\\ left\\ nasal\\ airway\\.\ \(1\)\
\-\ although\\ pleomorphic\\ adenomas\\ are\\ most\\ commonly\\ associated\\ with\\ the\\ parotid\\ and\\ other\\ salivary\\ glands\\,\\ a\\ number\\ of\\ intranasal\\ pleomorphic\\ adeomas\\ have\\ been\\ reported\\ and\\ commonly\\ occur\\ between\\ 30\\ and\\ 50\\ yrs\\ of\\ age\\.\\ \\ as\\ in\\ this\\ patient\\,\\ the\\ common\\ presentation\\ involves\\ nasal\\ obstruction\\.\\ \\ in\\ contrast\\,\\ a\\ report\\ of\\ epistaxis\\ is\\ also\\ common\\.\ \(0\)\
\-\ on\\ direct\\ visualization\\ this\\ adenoma\\ was\\ typical\\ for\\ a\\ pleomorphic\\ adenoma\\ and\\ described\\ as\\ a\\ smooth\\,\\ glistening\\ gray\\ mass\\.\ \(0\)\
\-\ malignant\\ tumors\\ should\\ also\\ be\\ considered\\ in\\ the\\ differential\\ including\\ cartilaginous\\ tumors\\ from\\ the\\ nasal\\ septum\\ \\(although\\ this\\ mass\\ appeared\\ to\\ originate\\ from\\ the\\ inferior\\ nasal\\ turbinate\\)\\,\\ squamous\\ cell\\ carcinoma\\ and\\ adenocarinoma\\.\\ \\ exicsional\\ biopsy\\ is\\ diagnostic\\ and\\ therapeutic\ \(0\)\
\-\ motoori\\,\\ k\\.\\ ajnr\\ 2000\\;\\ 21\\:\\ 1948\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nasal\\:\\ 0\\.11751530403599794\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.0667803505379726\ \(0\)\
\-\ adenoma\\:\\ 0\\.04956242155286128\ \(0\)\
\-\ epistaxis\\:\\ 0\\.04289209093299472\ \(0\)\
\-\ salivary\\:\\ 0\\.040076361015576906\ \(0\)\
\-\ passage\\:\\ 0\\.0369375754340279\ \(0\)\
\-\ 3\\-cm\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ \\-scattered\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ \\-mild\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ \\-interface\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ \\-modeling\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ \\-sinonasal\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ \\-inverted\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ \\-pleomorphic\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ \\-pyogenic\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ \\-granuloma\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ gravidarum\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ \\-hemangiopericytoma\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ adeomas\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ exicsional\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ motoori\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ 1948\\:\\ 0\\.030609438972105895\ \(0\)\
\-\ characteristics\\:\\ 0\\.02952201550346293\ \(0\)\
\-\ destruction\\:\\ 0\\.02930832342938825\ \(0\)\
\-\ incisors\\:\\ 0\\.028202677928494974\ \(0\)\
\-\ \\-juvenile\\:\\ 0\\.028202677928494974\ \(0\)\
\-\ intranasal\\:\\ 0\\.028202677928494974\ \(0\)\
\-\ \\-complex\\:\\ 0\\.02679481296978607\ \(0\)\
\-\ \\-hemangioma\\:\\ 0\\.02679481296978607\ \(0\)\
\-\ glistening\\:\\ 0\\.02679481296978607\ \(0\)\
\-\ turbinate\\:\\ 0\\.02679481296978607\ \(0\)\
\-\ adenocarinoma\\:\\ 0\\.02679481296978607\ \(0\)\
\-\ \\-ectopic\\:\\ 0\\.025795916884884054\ \(0\)\
\-\ osseous\\:\\ 0\\.025195365403650992\ \(0\)\
\-\ mucoperiosteal\\:\\ 0\\.02502111288726527\ \(0\)\
\-\ meatus\\:\\ 0\\.02385280651010828\ \(0\)\
\-\ ajnr\\:\\ 0\\.023389155841273133\ \(0\)\
\-\ ethmoidal\\:\\ 0\\.02261435184365435\ \(0\)\
\-\ commonly\\:\\ 0\\.02239257946844195\ \(0\)\
\-\ tumors\\:\\ 0\\.022289696928267367\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.021820799699965313\ \(0\)\
\-\ originate\\:\\ 0\\.021703364814253338\ \(0\)\
\-\ vault\\:\\ 0\\.02144604546649736\ \(0\)\
\-\ angiofibroma\\:\\ 0\\.02144604546649736\ \(0\)\
\-\ blockage\\:\\ 0\\.02144604546649736\ \(0\)\
\-\ \\-no\\:\\ 0\\.02098239479766221\ \(0\)\
\-\ k\\.\\:\\ 0\\.020771892638577368\ \(0\)\
\-\ mass\\:\\ 0\\.020633003592839663\ \(0\)\
\-\ nasopharyngeal\\:\\ 0\\.020573425923855325\ \(0\)\
\-\ lacrimal\\:\\ 0\\.020207590800043425\ \(0\)\
\-\ parotid\\:\\ 0\\.020207590800043425\ \(0\)\
\-\ inferior\\:\\ 0\\.020134141398326824\ \(0\)\
\-\ although\\:\\ 0\\.020041175559559747\ \(0\)\
\-\ left\\:\\ 0\\.019918859776519054\ \(0\)\
\-\ curative\\:\\ 0\\.019876652675722854\ \(0\)\
\-\ adenomas\\:\\ 0\\.01972230627790746\ \(0\)\
\-\ non\\-aggressive\\:\\ 0\\.019574529838953306\ \(0\)\
\-\ cartilaginous\\:\\ 0\\.019039284422886438\ \(0\)\
\-\ remodeling\\:\\ 0\\.018799725841334523\ \(0\)\
\-\ pedunculated\\:\\ 0\\.018799725841334523\ \(0\)\
\-\ yrs\\:\\ 0\\.018799725841334523\ \(0\)\
\-\ as\\:\\ 0\\.017952465359640662\ \(0\)\
\-\ glands\\:\\ 0\\.017631419464177532\ \(0\)\
\-\ 2000\\:\\ 0\\.017167768795342386\ \(0\)\
\-\ polyp\\:\\ 0\\.016889842727031493\ \(0\)\
\-\ lobular\\:\\ 0\\.0167587999215355\ \(0\)\
\-\ therapeutic\\:\\ 0\\.01669508763449315\ \(0\)\
\-\ airway\\:\\ 0\\.016510678518819717\ \(0\)\
\-\ maxillary\\:\\ 0\\.01622355450546863\ \(0\)\
\-\ infiltration\\:\\ 0\\.016168872710440367\ \(0\)\
\-\ appeared\\:\\ 0\\.016168872710440367\ \(0\)\
\-\ definite\\:\\ 0\\.016062026673403028\ \(0\)\
\-\ visualization\\:\\ 0\\.015664768509591417\ \(0\)\
\-\ common\\:\\ 0\\.015529633416363868\ \(0\)\
\-\ sinuses\\:\\ 0\\.015266242417256597\ \(0\)\
\-\ 44\\:\\ 0\\.015224658420566611\ \(0\)\
\-\ septum\\:\\ 0\\.015183566553736741\ \(0\)\
\-\ papilloma\\:\\ 0\\.014908784190685616\ \(0\)\
\-\ number\\:\\ 0\\.01479736643182624\ \(0\)\
\-\ granuloma\\:\\ 0\\.014584714955295966\ \(0\)\
\-\ gray\\:\\ 0\\.014516629985197439\ \(0\)\
\-\ squamous\\:\\ 0\\.014516629985197439\ \(0\)\
\-\ women\\:\\ 0\\.014416942117550109\ \(0\)\
\-\ direct\\:\\ 0\\.014015260176579752\ \(0\)\
\-\ involves\\:\\ 0\\.013789344921902454\ \(0\)\
\-\ most\\:\\ 0\\.013700244039778306\ \(0\)\
\-\ duct\\:\\ 0\\.013603050777831898\ \(0\)\
\-\ 21\\:\\ 0\\.013426244908292811\ \(0\)\
\-\ report\\:\\ 0\\.013281548045790839\ \(0\)\
\-\ hemangioma\\:\\ 0\\.013258007465980496\ \(0\)\
\-\ smooth\\:\\ 0\\.012987307669210663\ \(0\)\
\-\ pregnancy\\:\\ 0\\.012756440512027215\ \(0\)\
\-\ gland\\:\\ 0\\.012636696845113433\ \(0\)\
\-\ described\\:\\ 0\\.012636696845113433\ \(0\)\
\-\ \\(\\:\\ 0\\.01254100219173369\ \(0\)\
\-\ \\)\\:\\ 0\\.01238780715474488\ \(0\)\
\-\ considered\\:\\ 0\\.011977577808835578\ \(0\)\
\-\ cells\\:\\ 0\\.01189738435468749\ \(0\)\
\-\ typical\\:\\ 0\\.01189738435468749\ \(0\)\
\-\ diagnostic\\:\\ 0\\.011757544427125198\ \(0\)\
\-\ also\\:\\ 0\\.01169874717826494\ \(0\)\
\-\ structures\\:\\ 0\\.011423838489009424\ \(0\)\
\-\ 30\\:\\ 0\\.011410032418246787\ \(0\)\
\-\ 50\\:\\ 0\\.011288187557790987\ \(0\)\
\-\ occur\\:\\ 0\\.011132106349935897\ \(0\)\
\-\ reported\\:\\ 0\\.010816232120054902\ \(0\)\
\-\ calcification\\:\\ 0\\.010770088952976141\ \(0\)\
\-\ n\\/a\\:\\ 0\\.01074724530333016\ \(0\)\
\-\ malignant\\:\\ 0\\.01072455095965035\ \(0\)\
\-\ including\\:\\ 0\\.010713259170114318\ \(0\)\
\-\ extension\\:\\ 0\\.010591414309658518\ \(0\)\
\-\ biopsy\\:\\ 0\\.010526712644572086\ \(0\)\
\-\ obstruction\\:\\ 0\\.010463194613157761\ \(0\)\
\-\ presentation\\:\\ 0\\.010220141091982925\ \(0\)\
\-\ thickening\\:\\ 0\\.010057724200324138\ \(0\)\
\-\ air\\:\\ 0\\.010039106342194326\ \(0\)\
\-\ masses\\:\\ 0\\.010029834715264191\ \(0\)\
\-\ this\\:\\ 0\\.010011845972022218\ \(0\)\
\-\ areas\\:\\ 0\\.009983844344604397\ \(0\)\
\-\ density\\:\\ 0\\.00976260887798597\ \(0\)\
\-\ surrounding\\:\\ 0\\.009754046056822101\ \(0\)\
\-\ superior\\:\\ 0\\.009474804503660386\ \(0\)\
\-\ should\\:\\ 0\\.009459057437113888\ \(0\)\
\-\ mr\\:\\ 0\\.00942777594425845\ \(0\)\
\-\ differential\\:\\ 0\\.00941999940747545\ \(0\)\
\-\ between\\:\\ 0\\.009404498389667513\ \(0\)\
\-\ frontal\\:\\ 0\\.009320458105844991\ \(0\)\
\-\ aspect\\:\\ 0\\.009320458105844991\ \(0\)\
\-\ resection\\:\\ 0\\.009253179359445203\ \(0\)\
\-\ age\\:\\ 0\\.009030938630362174\ \(0\)\
\-\ from\\:\\ 0\\.008794692452459807\ \(0\)\
\-\ y\\.o\\:\\ 0\\.008563817474259374\ \(0\)\
\-\ carcinoma\\:\\ 0\\.008409471076443981\ \(0\)\
\-\ been\\:\\ 0\\.008072204477305524\ \(0\)\
\-\ cell\\:\\ 0\\.008014724692991271\ \(0\)\
\-\ enhancement\\:\\ 0\\.007953085993482763\ \(0\)\
\-\ signal\\:\\ 0\\.007823174757891592\ \(0\)\
\-\ evidence\\:\\ 0\\.007779314525579437\ \(0\)\
\-\ \\,\\:\\ 0\\.007519724042146871\ \(0\)\
\-\ bone\\:\\ 0\\.007373037088402326\ \(0\)\
\-\ in\\:\\ 0\\.0073159241343794265\ \(0\)\
\-\ soft\\:\\ 0\\.007225440152755382\ \(0\)\
\-\ bilateral\\:\\ 0\\.007200756004564041\ \(0\)\
\-\ the\\:\\ 0\\.007200483578313844\ \(0\)\
\-\ into\\:\\ 0\\.007060160999860093\ \(0\)\
\-\ tissue\\:\\ 0\\.007032712459904839\ \(0\)\
\-\ \\;\\:\\ 0\\.007032712459904839\ \(0\)\
\-\ man\\:\\ 0\\.007017124455173608\ \(0\)\
\-\ associated\\:\\ 0\\.007001606117735076\ \(0\)\
\-\ without\\:\\ 0\\.0069861568276325\ \(0\)\
\-\ was\\:\\ 0\\.006863038348706158\ \(0\)\
\-\ other\\:\\ 0\\.006839022738550168\ \(0\)\
\-\ well\\:\\ 0\\.00671208664225226\ \(0\)\
\-\ contrast\\:\\ 0\\.006641582245860782\ \(0\)\
\-\ have\\:\\ 0\\.006425132216545457\ \(0\)\
\-\ presents\\:\\ 0\\.006061264914958076\ \(0\)\
\-\ within\\:\\ 0\\.005660178501340561\ \(0\)\
\-\ and\\:\\ 0\\.005625281429131827\ \(0\)\
\-\ a\\:\\ 0\\.005508330580813906\ \(0\)\
\-\ be\\:\\ 0\\.004575544178277532\ \(0\)\
\-\ of\\:\\ 0\\.004449797947145392\ \(0\)\
\-\ ct\\:\\ 0\\.00415035990761126\ \(0\)\
\-\ are\\:\\ 0\\.004044700946283339\ \(0\)\
\-\ \\:\\:\\ 0\\.00392456533330092\ \(0\)\
\-\ is\\:\\ 0\\.00390479707211615\ \(0\)\
\-\ or\\:\\ 0\\.003477509545012873\ \(0\)\
\-\ patient\\:\\ 0\\.002974277537904125\ \(0\)\
\-\ for\\:\\ 0\\.0025316255161205383\ \(0\)\
\-\ on\\:\\ 0\\.0025135104596021806\ \(0\)\
\-\ with\\:\\ 0\\.0024375870018727027\ \(0\)\
\-\ \\.\\:\\ 0\\.0017256718936209995\ \(0\)\
\-\ to\\:\\ 0\\.0014828753765381466\ \(0\)\
